内皮氧化合成酶单体类型对氧化和过氧化产生的影响
Seham O Alsulami1, Tadeusz Malinski2, Howard D Dewald3
1Department of Chemistry and Biochemistry, Ohio University, Athens, OH, USA; Department of Biochemistry, Faculty of Sciences, University of Tabuk, Tabuk, Saudi Arabia.
Bioelectrochemistry (Amsterdam, Netherlands)
|October 19, 2024
概括
某些内皮氧化合成酶 (eNOS) 遗传变异影响心血管疾病 (CVD) 风险. 一些eNOS单质类型提供保护,而另一些通过改变氧化和过氧化含量增加易感性.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 心血管科学 心血管科学
- 分子生物学分子生物学
背景情况:
- 内皮氧化合成酶 (eNOS) 在血管健康中起着至关重要的作用.
- 特定的eNOS基因变异对氧化[NO]和过氧化[ONOO-]水平的影响以及它们与内皮功能障碍的关系尚不清楚.
- 心血管疾病 (CVD) 仍然是全球死亡的主要原因,需要对其遗传基础进行研究.
研究的目的:
- 研究四种临床上显著的eNOS基因多态化对[NO]/[ONOO-]比率的影响.
- 确定特定的eNOS遗传变异与内皮功能障碍之间的关联.
- 评估eNOS类型对心血管疾病易感性的潜在保护性或有害影响.
主要方法:
- 使用桑格序列和DNA电泳,对eNOS单核酸多态 (T-786C,C-665T,Glu298Asp) 和可变数量的并列重复 (intron 4 a/b/c) 的基因定型.
- 使用纳米传感器量化最大的氧化[NO]和过氧化[ONOO-]度.
- 通过传统和低温SDS-PAGE在人类静脉内皮细胞 (HUVEC) 中评估eNOS表达和二聚体与单聚体比.
主要成果:
- 恩诺斯单体H3 (GT/C C 4a/c等位基因) 与[NO]/[ONOO-]比率>2有关,这表明对心血管疾病有潜在的保护作用.
- eNOS单元类型H2 (G T/C C 4a/b) 和H5 (T T/C C 4b) 与[NO]/[ONOO-]比率<1有关,这表明对心血管疾病的敏感性增加.
- 特定的eNOS遗传变异显著改变[NO]/[ONOO-]比,反映不同程度的内皮功能障碍.
结论:
- 某些eNOS基因变异通过调节[NO]和[ONOO-]水平,显著影响内皮功能.
- 特定的eNOS单质表现出对心血管疾病风险的差异性影响,其中一些给予保护,而另一些增加易感性.
- [NO]/[ONOO-]比率是受到eNOS遗传变异影响的内皮功能障碍的有价值指标,为心血管疾病病变提供了洞察力.
更多相关视频
相关概念视频
Nitric Oxide Signaling Pathway
4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
Peroxisomes
11.1K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
11.1K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Antihypertensive Drugs: Vasodilators
483
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
483
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
136
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
136
Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3


